These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9816225)
1. Clonal analysis of bilateral breast cancer. Shibata A; Tsai YC; Press MF; Henderson BE; Jones PA; Ross RK Clin Cancer Res; 1996 Apr; 2(4):743-8. PubMed ID: 9816225 [TBL] [Abstract][Full Text] [Related]
2. The role of p53 mutations in bilateral breast carcinoma. Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152 [TBL] [Abstract][Full Text] [Related]
4. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125 [TBL] [Abstract][Full Text] [Related]
5. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation. Sekido Y; Umemura S; Takekoshi S; Suzuki Y; Tokuda Y; Tajima T; Osamura RY Int J Oncol; 2003 Jun; 22(6):1225-32. PubMed ID: 12738987 [TBL] [Abstract][Full Text] [Related]
7. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900 [TBL] [Abstract][Full Text] [Related]
8. Frequent p53 gene mutations and novel alleles in familial breast cancer. Glebov OK; McKenzie KE; White CA; Sukumar S Cancer Res; 1994 Jul; 54(14):3703-9. PubMed ID: 8033087 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522 [TBL] [Abstract][Full Text] [Related]
10. p53 mutations in breast cancer. Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133 [TBL] [Abstract][Full Text] [Related]
11. Discordance of p53 mutations of synchronous colorectal carcinomas. Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269 [TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786 [TBL] [Abstract][Full Text] [Related]
13. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. Mazoyer S; Lalle P; Moyret-Lalle C; Marçais C; Schraub S; Frappaz D; Sobol H; Ozturk M Oncogene; 1994 Apr; 9(4):1237-9. PubMed ID: 8134127 [TBL] [Abstract][Full Text] [Related]
14. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers. Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073 [TBL] [Abstract][Full Text] [Related]
15. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749 [TBL] [Abstract][Full Text] [Related]
16. TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Kandioler-Eckersberger D; Ludwig C; Rudas M; Kappel S; Janschek E; Wenzel C; Schlagbauer-Wadl H; Mittlböck M; Gnant M; Steger G; Jakesz R Clin Cancer Res; 2000 Jan; 6(1):50-6. PubMed ID: 10656431 [TBL] [Abstract][Full Text] [Related]
17. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences. Dahse R; Gärtner D; Werner W; Schubert J; Junker K Oncol Rep; 2003; 10(6):2033-7. PubMed ID: 14534739 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives. Lohmann D; Ruhri C; Schmitt M; Graeff H; Höfler H Diagn Mol Pathol; 1993 Mar; 2(1):36-41. PubMed ID: 8287224 [TBL] [Abstract][Full Text] [Related]
19. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan. Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734 [TBL] [Abstract][Full Text] [Related]
20. [P53 gene mutation in gallbladder cancer]. Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]